Evidence map›Paper›PMID 28445559›Full record

Observational studyJAMA cardiology2017

Association of US Centers for Medicare and Medicaid Services Hospital 30-Day Risk-Standardized Readmission Metric With Care Quality and Outcomes After Acute Myocardial Infarction: Findings From the National Cardiovascular Data Registry/Acute Coronary Treatment and Intervention Outcomes Network Registry-Get With the Guidelines.

Ambarish Pandey, Harsh Golwala, Hurst M Hall, Tracy Y Wang, Di Lu, Ying Xian, Karen Chiswell, Karen E Joynt, Abhinav Goyal, Sandeep R Das and 4 more

Abstract readObservational Study
In one paragraph

Observational study in JAMA cardiology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Observational
  11. Article
  12. Observational
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Type 2 Myocardial Infarction and the Hospital Readmission Reduction Program.Journal of the American College of Cardiology · 2018
    Article
  20. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Ambarish PandeyDivision of Cardiology, University of Texas Southwestern Medical Center, Dallas.
Harsh GolwalaBrigham and Women's Hospital Heart and Vascular Center, Boston, Massachusetts.
Hurst M HallDivision of Cardiology, University of Texas Southwestern Medical Center, Dallas.
Tracy Y WangDuke Clinical Research Institute, Durham, North Carolina.
Di LuDuke Clinical Research Institute, Durham, North Carolina.
Ying XianDuke Clinical Research Institute, Durham, North Carolina4Department of Neurology, Duke University Medical Center, Durham, North Carolina.
Karen ChiswellDuke Clinical Research Institute, Durham, North Carolina.
Karen E JoyntBrigham and Women's Hospital Heart and Vascular Center, Boston, Massachusetts.
Abhinav GoyalDivision of Cardiology, Emory University School of Medicine, Atlanta, Georgia.
Sandeep R DasDivision of Cardiology, University of Texas Southwestern Medical Center, Dallas.
Dharam KumbhaniDivision of Cardiology, University of Texas Southwestern Medical Center, Dallas.
Howard JulienDivision of Cardiology, Columbia University School of Medicine, New York, New York.
Gregg C FonarowRonald Reagan-UCLA Medical Center, Los Angeles, California8Associate Editor for Health Care Quality and Guidelines, JAMA Cardiology.
James A de LemosDivision of Cardiology, University of Texas Southwestern Medical Center, Dallas.

Funding

THE IMPACT OF PUBLIC REPORTING ON OUTCOMES AND CASE SELECTION FOR PCIK23HL109177 · NHLBI · WASHINGTON UNIVERSITY · PI JOYNT MADDOX, KAREN ELLEN · 2011 to 2017
$691k
NHLBI NIH HHS K23 HL109177
6 · The paper itself

Abstract

Importance: The US Centers for Medicare and Medicaid Services Hospital Readmissions Reduction Program penalizes hospitals with higher-than-expected risk-adjusted 30-day readmission rates (excess readmission ratio [ERR] > 1) after acute myocardial infarction (MI). However, the association of ERR with MI care processes and outcomes are not well established. Objective: To evaluate the association between ERR for MI with in-hospital process of care measures and 1-year clinical outcomes. Design, Setting, and Participants: Observational analysis of hospitalized patients with MI from National Cardiovascular Data Registry/Acute Coronary Treatment and Intervention Outcomes Network Registry-Get With the Guidelines centers subject to the first cycle of the Hospital Readmissions Reduction Program between July 1, 2008, and June 30, 2011. Exposures: The ERR for MI (MI-ERR) in 2011. Main Outcomes and Measures: Adherence to process of care measures during index hospitalization in the overall study population and risk of the composite outcome of mortality or all-cause readmission within 1 year of discharge and its individual components among participants with available Centers for Medicare and Medicaid Services-linked data. Results: The median ages of patients in the MI-ERR greater than 1 and tertiles 1, 2, and 3 of the MI-ERR greater than 1 groups were 64, 63, 64, and 63 years, respectively. Among 380 hospitals that treated a total of 176 644 patients with MI during the study period, 43% had MI-ERR greater than 1. The proportions of patients of black race, those with heart failure signs at admission, and bleeding complications increased with higher MI-ERR. There was no significant association between adherence to MI performance measures and MI-ERR (adjusted odds ratio, 0.94; 95% CI, 0.81-1.08, per 0.1-unit increase in MI-ERR for overall defect-free care). Among the 51 453 patients with 1-year outcomes data available, higher MI-ERR was associated with higher adjusted risk of the composite outcome and all-cause readmission within 1 year of discharge. This association was largely driven by readmissions early after discharge and was not significant in landmark analyses beginning 30 days after discharge. The MI-ERR was not associated with risk for mortality within 1 year of discharge in the overall and 30-day landmark analyses. Conclusions and Relevance: During the first cycle of the Hospital Readmissions Reduction Program, participating hospitals' risk-adjusted 30-day readmission rates following MI were not associated with in-hospital quality of MI care or clinical outcomes occurring after the first 30 days after discharge.

Indexed as

Adrenergic beta-AntagonistsAgedAngiotensin-Converting Enzyme InhibitorsAngiotensin Receptor AntagonistsAspirinCardiac RehabilitationCenters for Medicare and Medicaid Services, U.S.FemaleHumansHydroxymethylglutaryl-CoA Reductase InhibitorsMaleMiddle AgedMortalityMyocardial InfarctionMyocardial ReperfusionOutcome Assessment, Health CareAdrenergic beta-AntagonistsAngiotensin-Converting Enzyme InhibitorsAngiotensin Receptor AntagonistsAspirinHydroxymethylglutaryl-CoA Reductase InhibitorsPlatelet Aggregation Inhibitors

Identifiers

PMID28445559
PMCPMC5815085

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.